AXIOS September 11, 2023
Jason Millman

The Food and Drug Administration approved updated versions of COVID-19 vaccines on Monday, a key step in getting the new shots to Americans as early as this week.

Why it matters: The Biden administration has faced increasing calls to make the reformulated vaccines available more quickly as infections and hospitalizations ticked up in recent weeks.

  • Health officials have largely urged people concerned about protecting themselves against the late-summer surge to wait until the new boosters are available.

Driving the news: The FDA greenlit shots from Pfizer and Moderna that are targeted against the XBB.1.5 variant, which was the dominant strain circulating in the United States earlier this summer.

  • Scientists believe that the shots will be protective against...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
The telehealth background of Trump's FDA pick: 6 notes
President-elect Trump's picks for CDC, FDA, surgeon general: 31 notes
Opinion: RFK Jr. and MAHA should champion a Marshall Plan for obesity
Trump picks Johns Hopkins surgeon to head FDA: 10 things to know
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices

Share This Article